Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

2

4 posts
CChubb
TN inks MoUs to create 2,920 jobs across GCCs, manufacturing and higher education | Chennai News
Read More

TN inks MoUs to create 2,920 jobs across GCCs, manufacturing and higher education | Chennai News

  • 2026-08-02
In the presence of Tamil Nadu Chief Minister C. Joseph Vijay, Guidance Tamil Nadu on Thursday signed MoUs…
RRoche
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Read More

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc

  • 2026-07-23
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2,…
AAlps
Alps Group officer reports 2,000-share ownership
Read More

Alps Group officer reports 2,000-share ownership

  • 2026-06-10
SEC Form 3 FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF…
NNovartis
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Read More

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

  • 2026-03-27
– Acquisition brings together Excellergy’s differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of…
Switzerland
www.europesays.com